Benefits of switching from a conventional to a low-GDP bicarbonate/lactate- buffered dialysis solution in a rat model

Kidney International

Volumn 67, Issue 4, 2005, Pages 1559-1565

  Mortier, Siska ^a   Faict, Dirk ^b   Lameire, Norbert H ^b   De Vriese, An S ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

Biocompatibility; Buffer; Dialysate; Glucose degradation products; Peritoneal membrane

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BICARBONATE; GLUCOSE DEGRADATION PRODUCT; HALOTHANE; LACTIC ACID; PERITONEAL DIALYSIS FLUID; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; FEMALE; FIBROSIS; IMMUNOHISTOCHEMISTRY; NONHUMAN; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RAT; RAT STRAIN; ULTRAFILTRATION;

EID: 16244382350     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00237.x     Document Type: Article

References (21)

1. HONDA K, NITTA K, HORITA S, et al: Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 72:171-176, 1996
2. WILLIAMS JD, CRAIG KJ, TOPLEY N, et al: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13:470-479, 2002
3. WILLIAMS JD, CRAIG KJ, VON RUHLAND C, et al: The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int (Suppl):S43-S49, 2003
4. SUNDARAM S, CENDOROGLO M, COOKER LA, et al: Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro. Am J Kidney Dis 30:680-689, 1997
5. TOPLEY N, KAUR D, PETERSEN MM, et al: In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. J Am Soc Nephrol 7:218-224, 1996
6. HA H, YU MR, CHOI HN, et al: Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation. Peril Dial Int 20(Suppl 5):S10-S18, 2000
7. HEKKING LH, ZAREIE M, DRIESPRONG BA, et al: Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J Am Soc Nephrol 12:2775-2786, 2001
8. MORTIER S, FAICT D, SCHALKWIJK CG, et al: Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane. Kidney Int 66:1257-1265, 2004
9. TRANAEUS A: A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution-Clinical benefits. The Bicarbonate/Lactate Study Group. Pent Dial Int 20:516-523, 2000
10. JONES S, HOLMES CJ, KREDIET RT, et al: Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int 59:1529-1538, 2001
11. DE VRIESE AS, MORTIER S, CORNELISSEN M, et al: The effects of heparin administration in an animal model of chronic peritoneal dialysate exposure. Perit Dial Int 22:566-572, 2002
12. MORTIER S, DE VRIESE AS, LEYSSENS A, et al: Antibiotic administration in an animal model of chronic peritoneal dialysate exposure. Perit Dial Int 23:331-338, 2003
13. DE VRIESE AS, TILTON RG, STEPHAN CC, LAMEIRE NH: Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 12:1734-1741, 2001
14. MARGETTS PJ, KOLB M, GALT T, et al: Gene transfer of transforming growth factor-beta1 to the rat peritoneum: Effects on membrane function. J Am Soc Nephrol 12:2029-2039, 2001
15. MARGETTS PJ, GYORFFY S, KOLB M, et al: Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 13:721-728, 2002
16. DE VRIESE AS, FLYVBJERG A, MORTIER S, et al: Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J Am Soc Nephrol 14:2109-2118, 2003
17. YAMAGISHI S, YONEKURA H, YAMAMOTO Y, et al: Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem 272:8723-8730, 1997
18. MANDL-WEBER S, COHEN CD, HASLINGER B, et al: Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int 61:570-578, 2002
19. DAVIES SJ, PHILLIPS L, GRIFFITHS AM, et al: What really happens to people on long-term peritoneal dialysis? Kidney Int 54:2207-2217, 1998
20. ZWEERS MM, STRUIJK DG, SMIT W, KREDIET RT: Vascular endothelial growth factor in peritoneal dialysis: A longitudinal follow-up. J Lab Clin Med 137:125-132, 2001
21. WILLIAMS JD, TOPLEY N, CRAIG KJ, MACKENZIE RK, et al: The Euro-Balance Trial: The effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 66:408-418, 2004